NDAINTRAVENOUSSOLUTION
Approved
Mar 2014
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
NEURACEQ (florbetaben f 18) by Remedy Plan Therapeutics is positron emitting activity [moa]. First approved in 2014.
Drug data last refreshed 8h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NEURACEQ (florbetaben F-18) is a radioactive diagnostic agent administered intravenously as a solution that uses positron emission to enable imaging. It is designed to visualize amyloid pathology in the brain, primarily for diagnostic evaluation of cognitive impairment. The drug targets patients undergoing neuroimaging assessment for neurodegenerative disease confirmation.
Peak5.9 years to LOE
Product is at peak commercial maturity with established market presence; career growth may depend on pipeline expansion or market consolidation by sponsor.
Mechanism of Action
Positron Emitting Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on NEURACEQ offers specialized experience in nuclear/diagnostic medicine and healthcare systems relationships, but the zero linked job count suggests limited external recruiting momentum. Career progression depends heavily on internal mobility within Remedy Plan Therapeutics or lateral movement to growing diagnostic or imaging portfolios.
PET Imaging Specialist
Worked on NEURACEQ at Remedy Plan Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.